Department of Central Laboratory, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China.
Department of Biobank, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China.
Bioengineered. 2022 Jun;13(6):14844-14855. doi: 10.1080/21655979.2022.2096303.
Neutrophils are the most abundant circulating leukocytes and the first line of defense against invading pathogens. They are key components of the innate immune system. Neutrophils also cause tissue damage in various autoimmune and inflammatory diseases and play an important role in cancer progression. Due to the complex relationship between various diseases and neutrophils, these cells have become potentially important targets for therapeutic interventions. Monitoring neutrophils in the tumor microenvironment is critical for tumor treatment and prognostic analysis but remains challenging. Molecular imaging technology has made great progress as a valuable tool for noninvasively visualizing biological events and establishing effective cancer diagnoses and treatment methods. Molecular probes designed based on the characteristics of neutrophils, such as their flexible morphology, the abundance of surface receptors, and the absence of immunogenicity, have shown great potential. This has created an opportunity for novel ideas and research methods for the diagnosis and targeted therapy of inflammatory diseases and tumors, with the goal of integrated diagnosis and treatment. This review discusses the diverse tumor detection and diagnostic imaging strategies based on neutrophils. It is anticipated that neutrophil-based imaging will soon be gradually integrated into clinical applications.
中性粒细胞是循环白细胞中最丰富的一种,也是抵御入侵病原体的第一道防线。它们是先天免疫系统的关键组成部分。中性粒细胞也会在各种自身免疫性和炎症性疾病中引起组织损伤,并在癌症进展中发挥重要作用。由于各种疾病与中性粒细胞之间的复杂关系,这些细胞已成为治疗干预的潜在重要靶点。监测肿瘤微环境中的中性粒细胞对于肿瘤治疗和预后分析至关重要,但仍然具有挑战性。分子成像技术作为一种有价值的工具,在非侵入性可视化生物事件以及建立有效的癌症诊断和治疗方法方面取得了巨大进展。基于中性粒细胞的特性(如灵活的形态、丰富的表面受体和无免疫原性)设计的分子探针显示出巨大的潜力。这为炎症性疾病和肿瘤的诊断和靶向治疗提供了新的思路和研究方法,旨在实现综合诊断和治疗。本文讨论了基于中性粒细胞的多种肿瘤检测和诊断成像策略。预计基于中性粒细胞的成像将很快逐渐融入临床应用。